Mantis takes disparate sources of data to make synthetic datasets that can be used to build so-called "digital twins" of the ...
The fuller context of R3’s proposals, as well as activities of another stealth startup with related goals, have not ...
How North Carolina voters assess Republicans’ weighty health care moves could determine who replaces retiring Republican Thom ...
Supported by ADM, Primient, and the University of Illinois, iFAB is building shared precision fermentation infrastructure to reduce startup costs and strengthen US biotech capacity.
Industry executives at Future Food-Tech 2026 say precision fermentation’s growth is constrained by costly facilities, weak US infrastructure and limited government coordination, risking ...
It involves substances “not for human use.” ...
Consider the chief difference between living systems and electronics: The first is generally soft and squishy while the ...
The Cool Down on MSN
US pharma giant reaches $2.75 billion deal with China-based biotech company for AI-developed drugs
"This collaboration allows us to explore novel mechanisms and accelerate the identification of promising therapeutic ...
Medicine access delays often exceed 18 months, MSD Belgium highlights the need for reimbursement innovation, as well as data ...
ClearBridge Investments, an investment management company, released its “ClearBridge Small Cap Growth Strategy” Q4 2025 investor letter. A copy of the letter can be downloaded here. The Strategy ...
Tempest Therapeutics, Inc. (Nasdaq: TPST) ("Tempest”), a clinical-stage biotechnology company developing a pipeline of advan ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results